Sarvodaya Cancer Hospital Delhi NCR proudly announces the first-time availability of Radium-223 therapy in India for patients with castration-resistant prostate cancer (CRPC) and predominant skeletal metastases. This milestone marks a new era in precision oncology, offering hope to patients with advanced…
A New Ray of Hope: Terbium-161 Therapy Now Available at Theranostics Centre a unit of Sarvodaya Hospital
Theranos Care unit of Sarvodaya Hospital, Faridabad has become the first center in the Indian subcontinent to offer Terbium-161 therapy in India for patients with metastatic castration-resistant prostate cancer (mCRPC) and metastatic neuroendocrine tumors (NET) who have not responded to Lutetium-PSMA…